Summary
Viruses may cause Type 1 (insulin-dependent) diabetes. We wondered whether the number and function of natural killer cells, which are important in anti-viral defense, are disturbed in diabetic patients. We studied 16 recently diagnosed Type 1 diabetic patients, 18 Type 1 diabetic patients diagnosed more than 15 years previously, 18 Type 2 (non-insulin-dependent) diabetic patients and 23 control subjects. We determined the number of natural killer cells (expressed as log10%) using anti-Leu 11 monoclonal antibody and the function (in log10 lytic units) concurrently using a 51Cr release assay with K 562 as target cells. We found that the number of natural killer cells was reduced in Type 1 diabetes (1.01±0.04) as compared with Type 2 diabetic patients (1.16±0.04, p=0.004) and normal control subjects (1.16±0.04, p=0.006). To establish whether the reduced natural killer cell number is genetically determined we studied 19 identical twin pairs discordant for Type 1 diabetes; we found that even the non-diabetic co-twins had a reduced natural killer cell number (0.93±0.05, p= 0.0006) as compared with normal control subjects. Natural killer cell function was similar in all groups while natural killer activity per cell was significantly increased in the recently diagnosed diabetic patients (1.63±0.07) as compared with long-standing diabetic patients (1.26±0.26, p= 0.03) and controls subjects (1.36±0.07, p= 0.006). In conclusion the reduced number of natural killer cells in Type 1 diabetes appears to be genetically determined while their activity at diagnosis is increased.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cahill GF, McDevitt HO (1984) Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med 304: 1454–1465
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279–1282
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type I diabetes: possible monitors of active beta-cell damage. Lancet I: 668–672
Jackson RH, Morris MA, Haynes BF, Eisenbarth G (1982) Increased circulating Ia-antigen bearing T-cells in type I diabetes mellitus. N Engl J Med 305: 785–788
Alviggi L, Johnston C, Hoskins PJ, Tee DEH, Pyke DA, Leslie RDG, Vergani D (1984) Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet II: 4–6
Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Toniolo A, Onodera T (1984) Viruses and diabetes. In: Andreani D, Di Mario U, Federlin KF, Heding LG (eds) Immunology in Diabetes. Kimpton Medical publications, London, pp 71–92
Bottazzo GF, Pujol-Borrell R, Gale E (1985) Etiology of diabetes: the role of autoimmune mechanisms. In: Alberti KGMM, Krall LP (eds) The Diabetes Annual Vol 1. Elsevier Science Publishers BV, Amsterdam, pp 16–52
Welsh MR (1981) Natural cell-mediated immunity during viral infections. Curr Top Microbiol 92: 83–106
Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defenses against disease. Science 214: 24–30
Perussia B, Starr S, Abraham S, Fanning V, Trinchieri G (1983) Human natural killer cells analysed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. characterization of the lymphocyte subset reactive with B73.1. J Immunol 130: 2133–2141
Phillips JH, Babcock GF (1983) NKP-15: a monoclonal antibody reactive against purified natural killer cells and granulocytes. Immunol Lett 6: 143–149
West WH, Cannon GB, Kay HD, Bonnard GD, Herbermann RB (1977) Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterisation of effector cells. J Immunol 118: 355–361
Lanier LL, Phills JH, Warner NL, Babcock GF (1984) A human NK cell associated antigen defined by monoclonal antibody anti-Leu 11a (NKP-15): functional and two-color flow cytometry analysis. J Leukocyte Biol 35: 11–17
Chandy KG, Charles MA, Buckingham B, Waldeck N, Kershnar A, Gupta S (1984) Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus. Immunol Lett 8: 89–91
Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L, Gupta S, Charles MA (1986) Natural killer cell and islet killer cell activity in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 352–357
Pozzilli P, Sensi M, Gorsuch A, Bottazzo GF, Cudworth AG (1979) Evidence for raised K-cell levels in type I diabetes. Lancet II: 173–175
Phillips JH, Lanier LL (1985) A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with natural killer-sensitive tumor cell, K562. J Exp Med 161: 1464–1482
Trinchieri G, Perussia B (1984) Human natural killer cells: biologic and pathologic aspects. Lab Invest 50: 489–513
West WH, Cannon GB, Kay HD, Bonnard GD, Herberman RB (1977) Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J Immunol 118: 355–361
Böyun A (1968) Separation of leukocytes from blood and bonemarrow. Introduction. Scand J Clin Lab Invest 21 [Suppl] 97: 7
Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS (1981) Spontaneous human lymphocyte-mediated cytotoxicity against tumour target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1: 51–63
Timonen T, Stenins-Aarninla B (1985) Natural killer activity in asthma. Clin Exp Immunol 59: 85–90
Perussia B, Santoli D, Trinchieri G (1980) Interferon modulation of natural killer cell activity. Ann NY Acad Sci 350: 55–62
Herbermann RB, Nunn ME, Holden HT, Staal S, Djen JY (1977) Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer 19: 555–564
Koide Y, Takasugi M (1978) Augmentation of human natural cell-mediated cytotoxicity by a soluble factor. I. Production of N-cell-activating factor (NAF). J Immunol 121: 872–879
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hussain, M.J., Alviggi, L., Millward, B.A. et al. Evidence that the reduced number of natural killer cells in Type 1 (insulin-dependent) diabetes may be genetically determined. Diabetologia 30, 907–911 (1987). https://doi.org/10.1007/BF00295872
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00295872